A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD

NCT01157715 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration

Interventions

BIOLOGICAL: intravitreal injection of KH902

Sponsor

Chengdu Kanghong Biotech Co., Ltd.

Collaborators

[object Object]
[object Object]